Oral Antiemetic, Unspecified Dosage Form

Name: Negotiated commercial rates for Oral Antiemetic, Unspecified Dosage Form (HCPCS Q0181), in South Dakota
Creator: Tynbil
License: https://tynbil.com/terms

South Dakota rates for HCPCS Q0181

Unspecified oral dosage form, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High